Are There Age Requirements for IVF in China? Analysis of the Relationship Between Female Age and IVF Success Rate

Opening: Real consultation scenario + Direct answer (Module A)

"Doctor, I'm 38 years old. Can I still have IVF?" — This is a real question asked every day in the outpatient clinics of reproductive medicine centers. As a reproductive physician with over ten years of clinical experience in assisted reproduction, I need to answer similar questions almost every clinic day. The relationship between age and IVF is one of the most concerning and easily misunderstood topics for patients.

Direct answer: China has clear age requirements for female IVF patients, and age is the most core physiological factor affecting success rates, which cannot be completely circumvented through technical means. Official reproductive centers in China have clear age limits for women (usually ≤45 years old), and the success rates, medication protocols, and risk control strategies vary significantly across different age groups. Age essentially reflects the comprehensive level of ovarian reserve function, egg quality, and the normal rate of embryonic chromosomes.

Module D: Differences across age groups

Differences in Success Rates and Clinical Strategies Across Age Groups

The relationship between age and IVF live birth rate is represented by a very clear data curve in the field of reproductive medicine. The following data is based on large-sample statistics from multiple reproductive medicine centers in China (live birth rate per embryo transfer cycle):

Note: The above are general data ranges from domestic reproductive centers. Individual results vary significantly; specific outcomes depend on personal evaluation.

The table clearly shows: Age 35 is a significant turning point. After age 35, not only does the success rate gradually decline, but the rate of embryonic chromosomal abnormalities (such as aneuploidy) also increases significantly. By over 40, the live birth rate per transfer cycle is already below 30%, and the probability of achieving a live birth using one's own eggs after age 45 is extremely low.

Module L: Interpretation of examination indicators

Core Examination Indicators for Assessing Age and IVF Feasibility

Age is just a rough reference point. The real determinants of IVF strategy are the following three sets of indicators. In reproductive medicine centers, doctors combine these data to determine "when IVF is suitable" and "when it is not":

1. Ovarian Reserve Function Indicators

• AMH (Anti-Müllerian Hormone) — Reflects the number of remaining follicles in the ovaries. AMH < 1.0 ng/mL indicates diminished reserve, and < 0.5 ng/mL indicates severely low reserve. AMH is not affected by the menstrual cycle and can be checked at any time.
• FSH (Follicle-Stimulating Hormone) — Measured via blood test on days 2-4 of the menstrual cycle. FSH > 10 IU/L suggests diminished ovarian reserve, and > 15 IU/L usually predicts a poor response to stimulation.
• Antral Follicle Count (AFC) — Detected via transvaginal ultrasound in the early follicular phase. A total antral follicle count in both ovaries < 5-7 is considered low reserve.

Combining these three indicators with age allows for a relatively accurate assessment of the "true ovarian age." When is it suitable to start an IVF cycle immediately? When AMH ≥ 1.5, FSH ≤ 8, AFC ≥ 8, and age ≤ 38, it is usually suitable to proceed directly with a standard protocol. When is prior optimization or embryo accumulation needed? When AMH < 0.8 or FSH > 12, especially if age > 40, it is recommended to first evaluate the suitability of egg retrieval, and consider multiple retrievals to accumulate embryos if necessary.

2. Embryonic Chromosomal and Genetic Screening

The older the age, the higher the error rate in egg meiosis, leading to an increased rate of embryonic aneuploidy. For a 40-year-old woman, the rate of chromosomally normal embryos may be less than 30%. Why does age affect embryo quality? Because a woman's entire supply of egg cells is formed at birth. As age increases, mitochondrial function within the cells declines, and the error rate in spindle assembly rises, directly causing embryonic chromosomal abnormalities. How to determine if PGT-A (Preimplantation Genetic Testing for Aneuploidies) is needed? It is recommended for women aged ≥ 38, those with a history of recurrent implantation failure, or those with a history of pregnancy with chromosomal abnormalities.

3. Uterine Cavity Environment Assessment

Increasing age can also affect endometrial receptivity. Hysteroscopy and endometrial gene chip analysis (ERA) can determine if the endometrium is suitable for embryo implantation. What needs attention? Even if an older woman obtains a chromosomally normal embryo, transfer may still fail due to reduced endometrial blood flow and decreased endometrial receptivity. This aspect is easily overlooked.

Module C: The doctor's perspective

Reproductive Physician's Perspective: Age is Not the Only Criterion, But It Is Irreversible

In clinical decision-making, we do not refuse a patient solely based on age, but we treat age as the most important risk factor to manage. Why do doctors place so much emphasis on age? Because age is related to the "quality" of the eggs, not just the "quantity." Quantity can be increased with medication stimulation, but quality cannot be reversed by any currently available medication. The difference in chromosomal normality rates between eggs from a 35-year-old and a 42-year-old is fundamental.

When is it not suitable to proceed with IVF immediately? If a woman is over 43 with AMH < 0.3, or FSH > 20, using her own eggs for an IVF cycle is generally not recommended. The probability of retrieving eggs is extremely low, the cycle cancellation rate is high, and the economic and time costs are severely disproportionate to the potential benefit. In such cases, consulting about egg donation or embryo donation is more appropriate. How to choose? The decision should be made jointly by the doctor and the patient, considering the patient's desire for childbearing, financial situation, psychological resilience, and family support system.

Module G: The most easily overlooked details

Easily Overlooked Details: Male Age, Embryo Freezing, and Genetic Screening

While focusing on the woman's age, several details are easily overlooked but have a substantial impact on IVF outcomes:

• Male age also affects embryo quality. After a man turns 40, his sperm DNA fragmentation index (DFI) increases, which raises the risk of embryo developmental arrest and miscarriage. What preparations are needed? The male partner should simultaneously undergo semen analysis, sperm morphology assessment, and DFI testing. If DFI > 30%, lifestyle adjustments or medication therapy are recommended before starting the IVF cycle.
• Embryo freezing strategy is crucial for older women. For women with diminished ovarian reserve (e.g., AMH < 0.8), doctors often recommend "embryo banking" — performing multiple egg retrievals, freezing the resulting embryos, and accumulating them until a sufficient number is reached before a single transfer. What is the specific process? After each retrieval, any transferable embryos formed are frozen. The next retrieval is scheduled 2-3 months later. After accumulating 3-5 embryos, a transfer is scheduled. How long does it take? The entire embryo banking cycle usually takes 6-12 months.
• The value of PGT-A screening is underestimated in the older population. Many patients believe that "as long as the embryo morphology is good, it's fine," but morphological grading cannot determine chromosomal normality. For women aged ≥ 38, PGT-A can significantly increase the live birth rate per single transfer and reduce the miscarriage rate. What are the risks? Embryo biopsy may cause some damage to the embryo (probability ~1-2%), and there is a possibility that no embryo is available for transfer after screening, requiring psychological preparation in advance.

Module N: Special situation management

Special Situation Management: Premature Ovarian Insufficiency, Egg Donation, and Embryo Donation

In clinical practice, we often encounter the following special situations that require separate discussion:

Premature Ovarian Insufficiency (POI)

For women who experience ovarian failure before age 40 (AMH < 0.1, FSH > 25, amenorrhea), the success rate of IVF using their own eggs is extremely low. When is egg donation suitable? Patients diagnosed with POI, without genetic diseases, with normal uterine function, a clear desire for childbearing, and who accept the ethical process of egg donation, may consider egg donation IVF. What is the specific process? Register on the waiting list at an official reproductive center; after an egg source is obtained, in vitro fertilization is performed using the partner's sperm; the resulting embryos are screened and transferred to the woman's uterus. What needs attention? Egg donation is a form of third-party assisted reproduction with strict legal and ethical restrictions in China. It must be conducted through official channels, and private transactions are strictly prohibited.

Advanced Age Combined with Uterine Fibroids or Adenomyosis

Increasing age is accompanied by a higher probability of uterine pathologies. If combined with submucosal fibroids or severe adenomyosis, embryo implantation may be affected. How to assess? The location and size of the lesions are identified through transvaginal ultrasound and hysteroscopy. If fibroids compress the endometrium or adenomyosis causes abnormal uterine cavity shape, hysteroscopic surgery is recommended before considering transfer. How long does it take? Recovery typically takes 3-6 months after surgery.

Embryo Donation

For older women who have undergone multiple egg retrievals without obtaining a transferable embryo, embryo donation is another option. Donated embryos come from surplus embryos voluntarily donated by other IVF families. What needs attention? Recipients of donated embryos need to undergo comprehensive psychological evaluation and ethical counseling, and must sign legal documents. The number of reproductive centers in China that offer embryo donation is limited, so it is necessary to inquire in advance.

Module R: Practitioner observations

Practitioner Observations: Real-World Considerations in Age and IVF Decision-Making

In over ten years of clinical work, I have observed several phenomena worth sharing:

• Cognitive lag is very common. Many women only realize the impact of age on fertility at 38-40, having had no prior concept of ovarian reserve or AMH. By the time they come for consultation, their AMH is already below 0.5, and the optimal window has been missed. It is recommended that all women with childbearing plans undergo a basic fertility assessment between ages 30-35, including AMH, FSH, and antral follicle count.
• The psychological trap of "trying one more time." For women over 40, the rate of normal embryos per retrieval is declining. However, many repeatedly attempt cycles because "this embryo's morphology looks good," ultimately spending far more time and money than anticipated. From a medical perspective, if two consecutive retrievals fail to yield a chromosomally normal embryo, other paths (egg donation or discontinuation) should be seriously considered, rather than repeating the process indefinitely.
• Insufficient male involvement. In outpatient clinics, approximately 60% of couples are represented by the woman alone, with the male partner rarely participating. In reality, a man's age, lifestyle habits (smoking, alcohol consumption, staying up late) significantly impact sperm quality and, consequently, embryo quality. It is recommended that men participate in the evaluation and preconception health optimization simultaneously.
• Psychological support is severely underestimated. Older women undergoing IVF often bear immense social pressure and self-anxiety. This psychological state can affect endocrine function and ovarian response. Appropriate psychological interventions (such as mindfulness training, psychological counseling) during treatment can positively contribute to the outcome.

Ending: Doctor's advice

Doctor's Advice: An Age-Based IVF Decision-Making Roadmap

Based on current clinical evidence and the actual situation of assisted reproduction in China, I offer the following suggestions for reference:

This article is written based on the clinical consensus of China's assisted reproductive industry and the practices of mainstream reproductive medicine centers. It aims to provide objective medical knowledge for reference and does not constitute personal medical advice. Every patient's situation is unique. Please consult a licensed reproductive physician for specific diagnosis and treatment plans.